Streetwise Articles



Analyst Says Anti-Drone Co. On ‘Verge of Inflection Point’
Source: Streetwise Reports  (8/7/22)
Governments all over the world are more concerned than ever about the growing risk from drones that can carry weapons, engage in chemical warfare, and disrupt flights. One Australian company is using technology to mitigate the threat — without ever firing a bullet. More >


Biotech Co. Awakes To Good News
Source: Clive Maund  (8/6/22)
Awakn Life Sciences Corp.'s rating went to an Immediate Speculative Buy after it received substantial funding from the UK government. Expert Clive Maund shares his thoughts on the development. More >


Biopharma Co. Planning BLA for DMD Drug
Source: Yun Zhong, Ph.D.  (8/5/22)
Sarepta Therapeutics Inc. recently announced that it intends to submit a BLA to the U.S. FDA for its SRP-9001, a gene therapy to treat Duchenne muscular dystrophy. Equity research firm BTIG LLC advised in a research update that SRP-9001 seems to have met the necessary criteria for receiving accelerated approval and it expects an AdCom will be established shortly. BTIG stated that it rates Sarepta Therapeutics as a "Buy" and has a $125 price target for the company's shares. More >


SRT Device Maker's Revenues Rise 124% in Q2
Source: Streetwise Reports  (8/5/22)
Sensus Healthcare Inc.'s shares traded 30% higher after the company reported it achieved a 124% YoY increase in revenue in Q2/22. The company advised that demand continues to remain strong for its superficial radiation therapy (SRT) devices which provide minimally invasive and non-surgical alternatives for non-melanoma skin cancer & keloid removal. More >


Adrian Day

Global Equities Offer Yields up to 8%
Source: Adrian Day  (8/5/22)
Expert Adrian Day reviews results and developments from some of his favorite non-resource companies. He believes all three are solid dividend payers, and for investors seeking income attractive buys. More >


Environmental Tech Co. Builds up to a Major Bull Market
Source: Clive Maund  (8/4/22)
After a few weeks of observation, expert Clive Maund believes Bion Environmental Technologies Inc. may be due for a major uptrend and is building up to a major bull market. More >


Seabridge Expands KSM Project to Copper-Rich Deposits
Source: Streetwise Reports  (8/4/22)
This junior releases a preliminary economic assessment focusing on new copper-rich deposits on its massive KSM site in the Golden Triangle. More >


Ins. Provider to Offer Med Tech Co.'s CGM to its 45M Members
Source: Streetwise Reports  (8/4/22)
Shares of Senseonics Holdings Inc. traded 31.5% higher yesterday after the company reported that Elevance Health (formerly Anthem) has approved coverage of its Eversense® E3 implantable continuous glucose monitor to its forty-five million covered members. More >


ChemoCentryx Shares Double on $4B Cash Bid from Amgen
Source: Streetwise Reports  (8/4/22)
Shares of ChemoCentryx Inc. traded 110% higher after the company reported it agreed to be acquired by Amgen Inc. for $52.00 per share in an all-cash deal valued at $4 billion. With the purchase, Amgen aims to cement its leadership position in inflammation and nephrology with the addition of ChemoCentryx's TAVNEOS® (avacopan) which the U.S. FDA approved late last year to treat ANCA-associated vasculitis, a serious autoimmune disease. More >


Analyst Says PEA Adds 'Considerable Value' to KSM
Source: David Talbot  (8/4/22)
Seabridge Gold Inc.'s copper-rich expansion at its KSM project in the Golden Triangle gets one analyst to raise his target price for the company. More >


MRI Device Maker's Earnings Come In at High End of Forecasts
Source: Streetwise Reports  (8/3/22)
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40). More >


Gold and Silver Junior ‘A Worthy Addition to a Junior Portfolio'
Source: Clive Maund  (8/3/22)
Expert Clive Maund reviews his opinion on gold and silver junior Western Exploration Inc. after it had what he calls "an impressive rally" in June. More >


Nanotech Co. Aims To Make EV Batteries Safer, Cheaper
Source: Streetwise Reports  (8/2/22)
New patents could help Meta Materials Inc. improve safety and reduce the cost of lithium-ion batteries needed for the electric vehicle industry. More >


Silver Mine Produces While Plant Waits for Power
Source: Streetwise Reports  (8/2/22)
MAG Silver Corp.'s Juanicipio project continues to deliver silver as the company waits for local officials to give the go-ahead to power up its own plant. More >


Gold Co.'s Stock Price Has Taken a 'Startling Drop'
Source: Clive Maund  (8/2/22)
Expert Clive Maund shares the recent drop in Getchell Gold Corp.'s stock price and his rating of the company in light of the news. More >


Expert Says Biotech Co. Is a ‘Strong Buy’ After Phase 2 Study
Source: Clive Maund  (8/2/22)
Expert Clive Maund gives his assessment of biotech Algernon Pharmaceuticals Inc. after its Phase 2 study of Ifenprodil. More >


Expert Rates Mining Co. A 'Strong Speculative Buy'
Source: Clive Maund  (8/2/22)
Expert Clive Maund shares his assessment of Omineca Mining and Metals Ltd. since its stock is currently inexpensive, and tells you whether he believes this stock is a Buy or a "goodbye." More >


Expert Believes Health Co. Blooms With Opportunity
Source: Clive Maund  (8/2/22)
Expert Clive Maund touches on the latest news with Bloom Health Partners Inc. from the enthusiastic buying toward the end of June to whether he believes the health company is still bullish. More >


Tech Co. ‘Right at the Point of Breakout'
Source: Clive Maund  (8/2/22)
BioLargo Inc. seemed to be very close to breaking out of its tight trading range on July 20, 2022, after remaining in the same place for a month. Expert Clive Maund goes over this update and his assessment of the company after this news. More >


Turn-Key Solar Provider Adds Record Number of Clients in Q2
Source: Streetwise Reports  (8/2/22)
SunPower Corp. shares traded over 9% higher after the company reported Q2/22 financial results highlighting a 63% YoY increase in revenue. The firm confirmed its previous guidance indicating that it expects to add 73,000 to 80,000 net new customers in FY/2022. More >


EV Co. Buys Romeo Power To Bring Battery Production In-House
Source: Streetwise Reports  (8/1/22)
Shares of lithium-ion battery manufacturer Romeo Power Inc. traded 26% higher after the company reported it entered into a definitive agreement to be acquired by commercial EV truck maker Nikola Corp. in an all-stock transaction valued at $144 million. More >


Study Review Shows Greater Promise for Biopharma Co.'s Cough Treatment
Source: Andre Uddin  (8/1/22)
After Algernon Pharmaceuticals Inc.'s Ifenprodil treatment for chronic cough was reviewed in a Phase 2 analysis, analysts at Research Capital Corp. noted that it is maintaining its Speculative Buy rating on the company. More >


Argentina Lithium Active At Salar De Rincon
Source: The Critical Investor  (7/30/22)
The Critical Investor takes a look at one junior lithium play in Argentina that just had some success with the drill bit and is building its prospective land package — real estate that should only increase in value as lithium carbonate prices hover around US$75,000 per tonne. More >


Drug Candidate Repairs Motor/Sensory Function in Stroke
Source: Streetwise Reports  (7/29/22)
Shares of NervGen Pharma Corp. traded 28% higher yesterday after the company reported that, in a landmark pre-clinical animal study, its NVG-291-R demonstrated significant functional repair to damage from ischemic stroke seven days following the event. More >


Oil & Gas Services Co. Posts 90% Increase in Q2 Revenues
Source: Streetwise Reports  (7/29/22)
Energy industry service company Mammoth Energy Services Inc.'s shares traded 22% higher after the company reported Q2/22 financial results that included significant increases in quarterly revenue, net income, and adjusted EBITDA. More >


Showing Results: 1 to 25 of 21125 Next

Notable Quotes

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts